Bisola Olubunmi Ojikutu, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trust | 7 | 2024 | 530 | 2.470 |
Why?
|
| HIV Infections | 35 | 2024 | 17351 | 2.400 |
Why?
|
| Anti-HIV Agents | 10 | 2021 | 4527 | 1.270 |
Why?
|
| Intention | 5 | 2022 | 347 | 1.070 |
Why?
|
| Influenza Vaccines | 3 | 2022 | 768 | 1.070 |
Why?
|
| Risk-Taking | 3 | 2021 | 1038 | 0.940 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2021 | 4016 | 0.930 |
Why?
|
| Sexual Behavior | 5 | 2022 | 2180 | 0.910 |
Why?
|
| Religion | 3 | 2022 | 372 | 0.780 |
Why?
|
| Residence Characteristics | 4 | 2024 | 2093 | 0.770 |
Why?
|
| Mass Screening | 6 | 2024 | 5428 | 0.680 |
Why?
|
| Sweating | 1 | 2020 | 155 | 0.670 |
Why?
|
| Emigrants and Immigrants | 2 | 2016 | 543 | 0.630 |
Why?
|
| Sexual Partners | 3 | 2021 | 796 | 0.610 |
Why?
|
| Prejudice | 1 | 2022 | 570 | 0.590 |
Why?
|
| Health Communication | 1 | 2020 | 213 | 0.580 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2021 | 662 | 0.580 |
Why?
|
| Heterosexuality | 1 | 2019 | 309 | 0.560 |
Why?
|
| Vaccines | 2 | 2023 | 844 | 0.550 |
Why?
|
| Crime | 1 | 2018 | 202 | 0.540 |
Why?
|
| Prisons | 1 | 2018 | 174 | 0.530 |
Why?
|
| Prisoners | 1 | 2018 | 314 | 0.480 |
Why?
|
| Social Class | 2 | 2021 | 2004 | 0.480 |
Why?
|
| Stereotyping | 1 | 2016 | 239 | 0.460 |
Why?
|
| Health Services Accessibility | 6 | 2014 | 5440 | 0.460 |
Why?
|
| Cytomegalovirus Infections | 1 | 2020 | 831 | 0.450 |
Why?
|
| Influenza, Human | 2 | 2022 | 1521 | 0.450 |
Why?
|
| Urban Population | 1 | 2022 | 2036 | 0.450 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2024 | 3205 | 0.430 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2014 | 1897 | 0.420 |
Why?
|
| Lymphocytes | 1 | 2020 | 2612 | 0.410 |
Why?
|
| Truth Disclosure | 1 | 2016 | 434 | 0.390 |
Why?
|
| Attitude to Health | 1 | 2020 | 2025 | 0.380 |
Why?
|
| Rural Population | 1 | 2022 | 2285 | 0.370 |
Why?
|
| Leadership | 2 | 2024 | 1385 | 0.360 |
Why?
|
| United States | 16 | 2024 | 72334 | 0.350 |
Why?
|
| Pandemics | 5 | 2022 | 8654 | 0.340 |
Why?
|
| Homosexuality, Male | 3 | 2022 | 1334 | 0.320 |
Why?
|
| Health Plan Implementation | 2 | 2007 | 337 | 0.300 |
Why?
|
| Humans | 56 | 2024 | 761504 | 0.290 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 7827 | 0.280 |
Why?
|
| Rheumatic Diseases | 2 | 2024 | 649 | 0.280 |
Why?
|
| Healthcare Disparities | 2 | 2024 | 3358 | 0.260 |
Why?
|
| Adult | 24 | 2024 | 221177 | 0.260 |
Why?
|
| Anti-Retroviral Agents | 3 | 2021 | 1784 | 0.250 |
Why?
|
| Women's Health Services | 1 | 2005 | 88 | 0.240 |
Why?
|
| Male | 28 | 2024 | 360804 | 0.230 |
Why?
|
| Qualitative Research | 3 | 2024 | 3023 | 0.230 |
Why?
|
| Female | 28 | 2024 | 392644 | 0.220 |
Why?
|
| Patient-Centered Care | 1 | 2013 | 1421 | 0.220 |
Why?
|
| Quality of Health Care | 2 | 2018 | 4330 | 0.220 |
Why?
|
| Universal Precautions | 1 | 2022 | 34 | 0.210 |
Why?
|
| Patient Care Team | 1 | 2013 | 2521 | 0.200 |
Why?
|
| Delivery of Health Care | 3 | 2021 | 5336 | 0.200 |
Why?
|
| Social Stigma | 3 | 2024 | 769 | 0.200 |
Why?
|
| Zimbabwe | 4 | 2021 | 135 | 0.190 |
Why?
|
| Vaccination | 3 | 2022 | 3384 | 0.190 |
Why?
|
| Hepatitis B Vaccines | 1 | 2022 | 178 | 0.190 |
Why?
|
| Immunization Schedule | 1 | 2022 | 227 | 0.180 |
Why?
|
| Middle Aged | 15 | 2024 | 220895 | 0.180 |
Why?
|
| Massachusetts | 5 | 2023 | 8830 | 0.180 |
Why?
|
| Young Adult | 9 | 2024 | 59243 | 0.170 |
Why?
|
| Masks | 1 | 2022 | 208 | 0.170 |
Why?
|
| Seroepidemiologic Studies | 1 | 2020 | 397 | 0.160 |
Why?
|
| School Health Services | 1 | 2022 | 384 | 0.160 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2007 | 2199 | 0.160 |
Why?
|
| Disease Outbreaks | 1 | 2008 | 1749 | 0.160 |
Why?
|
| Southeastern United States | 1 | 2018 | 91 | 0.150 |
Why?
|
| Public Health | 2 | 2024 | 2669 | 0.150 |
Why?
|
| South Africa | 3 | 2008 | 1842 | 0.150 |
Why?
|
| Sampling Studies | 1 | 2019 | 615 | 0.150 |
Why?
|
| Medication Adherence | 2 | 2021 | 2176 | 0.150 |
Why?
|
| Pleural Effusion | 1 | 2020 | 341 | 0.140 |
Why?
|
| Musculoskeletal Diseases | 1 | 2023 | 598 | 0.140 |
Why?
|
| Cultural Diversity | 1 | 2020 | 369 | 0.140 |
Why?
|
| Leukocyte Count | 1 | 2020 | 1596 | 0.130 |
Why?
|
| Boston | 4 | 2024 | 9326 | 0.130 |
Why?
|
| Africa | 1 | 2018 | 709 | 0.130 |
Why?
|
| Adolescent | 8 | 2024 | 88319 | 0.130 |
Why?
|
| Caribbean Region | 1 | 2016 | 191 | 0.130 |
Why?
|
| Information Dissemination | 1 | 2024 | 1126 | 0.130 |
Why?
|
| New York City | 1 | 2018 | 731 | 0.130 |
Why?
|
| Seasons | 1 | 2022 | 1520 | 0.130 |
Why?
|
| Zambia | 1 | 2016 | 262 | 0.130 |
Why?
|
| Thailand | 1 | 2016 | 287 | 0.130 |
Why?
|
| HIV-1 | 3 | 2015 | 6863 | 0.130 |
Why?
|
| Women's Health | 1 | 2005 | 2065 | 0.120 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 1078 | 0.120 |
Why?
|
| Cross-Sectional Studies | 5 | 2023 | 26125 | 0.120 |
Why?
|
| Nevirapine | 1 | 2015 | 273 | 0.120 |
Why?
|
| Awareness | 1 | 2018 | 648 | 0.120 |
Why?
|
| Risk Factors | 7 | 2020 | 74206 | 0.120 |
Why?
|
| Hepatitis C | 1 | 2024 | 1584 | 0.110 |
Why?
|
| Resilience, Psychological | 1 | 2022 | 788 | 0.110 |
Why?
|
| Mexico | 1 | 2016 | 764 | 0.110 |
Why?
|
| Radiography, Thoracic | 1 | 2020 | 1302 | 0.110 |
Why?
|
| California | 1 | 2018 | 1429 | 0.110 |
Why?
|
| Health Policy | 2 | 2023 | 2684 | 0.110 |
Why?
|
| Gender Identity | 1 | 2019 | 766 | 0.110 |
Why?
|
| Health Status Disparities | 2 | 2024 | 1852 | 0.110 |
Why?
|
| Brazil | 1 | 2016 | 1230 | 0.100 |
Why?
|
| World Health Organization | 2 | 2007 | 1322 | 0.100 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2018 | 2571 | 0.090 |
Why?
|
| Nigeria | 1 | 2014 | 770 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2022 | 2598 | 0.090 |
Why?
|
| Communication Barriers | 1 | 2014 | 413 | 0.090 |
Why?
|
| Drug Resistance, Viral | 1 | 2015 | 862 | 0.090 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 3156 | 0.090 |
Why?
|
| Genes, MHC Class I | 1 | 2010 | 235 | 0.090 |
Why?
|
| Emigration and Immigration | 1 | 2012 | 397 | 0.080 |
Why?
|
| HLA-B Antigens | 1 | 2010 | 317 | 0.080 |
Why?
|
| Health Surveys | 1 | 2019 | 4061 | 0.080 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2017 | 942 | 0.080 |
Why?
|
| Professional-Patient Relations | 1 | 2013 | 726 | 0.080 |
Why?
|
| Cohort Studies | 5 | 2021 | 41487 | 0.080 |
Why?
|
| Hemoglobins, Abnormal | 1 | 2008 | 119 | 0.070 |
Why?
|
| Viral Load | 4 | 2021 | 3332 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2019 | 23995 | 0.070 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2008 | 67 | 0.070 |
Why?
|
| Self Report | 1 | 2018 | 3724 | 0.070 |
Why?
|
| Educational Status | 1 | 2014 | 2522 | 0.070 |
Why?
|
| Interviews as Topic | 1 | 2013 | 2696 | 0.070 |
Why?
|
| Income | 1 | 2014 | 1877 | 0.060 |
Why?
|
| Candidiasis | 1 | 2008 | 365 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 12059 | 0.060 |
Why?
|
| Antigen Presentation | 1 | 2010 | 1251 | 0.060 |
Why?
|
| Botswana | 1 | 2008 | 1048 | 0.060 |
Why?
|
| Women's Rights | 1 | 2005 | 65 | 0.060 |
Why?
|
| Refusal to Participate | 1 | 2024 | 31 | 0.060 |
Why?
|
| Aged | 7 | 2024 | 169289 | 0.060 |
Why?
|
| South Carolina | 1 | 2024 | 100 | 0.060 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2008 | 662 | 0.060 |
Why?
|
| Incidence | 2 | 2022 | 21353 | 0.060 |
Why?
|
| Chicago | 1 | 2024 | 254 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2019 | 3429 | 0.060 |
Why?
|
| Mental Health | 1 | 2018 | 3250 | 0.060 |
Why?
|
| Occupational Groups | 1 | 2022 | 5 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2015 | 4369 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3084 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3204 | 0.050 |
Why?
|
| Prevalence | 1 | 2019 | 15732 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2017 | 9318 | 0.050 |
Why?
|
| Lung | 1 | 2020 | 10000 | 0.050 |
Why?
|
| Logistic Models | 2 | 2012 | 13255 | 0.050 |
Why?
|
| Primary Health Care | 1 | 2017 | 4686 | 0.040 |
Why?
|
| Philadelphia | 1 | 2021 | 266 | 0.040 |
Why?
|
| Los Angeles | 1 | 2021 | 243 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2012 | 9646 | 0.040 |
Why?
|
| Aging | 1 | 2019 | 8708 | 0.040 |
Why?
|
| Comorbidity | 3 | 2020 | 10508 | 0.040 |
Why?
|
| Community Health Services | 1 | 2024 | 656 | 0.040 |
Why?
|
| Forecasting | 1 | 2008 | 2928 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2018 | 42230 | 0.040 |
Why?
|
| Internal Medicine | 1 | 2024 | 1051 | 0.030 |
Why?
|
| Child | 4 | 2023 | 80153 | 0.030 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2008 | 2151 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2022 | 846 | 0.030 |
Why?
|
| Proton-Translocating ATPases | 1 | 1996 | 112 | 0.030 |
Why?
|
| Vacuoles | 1 | 1996 | 228 | 0.030 |
Why?
|
| Geriatrics | 1 | 2019 | 388 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2019 | 803 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2019 | 765 | 0.030 |
Why?
|
| Schools | 1 | 2022 | 1489 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2021 | 1505 | 0.030 |
Why?
|
| Counseling | 1 | 2021 | 1547 | 0.030 |
Why?
|
| Students | 1 | 2022 | 1741 | 0.030 |
Why?
|
| Osteoclasts | 1 | 1996 | 711 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 64680 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2018 | 1351 | 0.020 |
Why?
|
| Isoenzymes | 1 | 1996 | 1687 | 0.020 |
Why?
|
| HIV | 1 | 2018 | 1582 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2024 | 80636 | 0.020 |
Why?
|
| Sex Factors | 1 | 2005 | 10552 | 0.020 |
Why?
|
| Poverty | 1 | 2022 | 2698 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2020 | 1936 | 0.020 |
Why?
|
| HLA-C Antigens | 1 | 2010 | 140 | 0.020 |
Why?
|
| HLA-A Antigens | 1 | 2010 | 223 | 0.020 |
Why?
|
| HIV Long-Term Survivors | 1 | 2010 | 121 | 0.020 |
Why?
|
| HIV Antigens | 1 | 2010 | 325 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2015 | 2645 | 0.020 |
Why?
|
| Pregnancy | 1 | 2008 | 29874 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2017 | 3575 | 0.020 |
Why?
|
| Developing Countries | 1 | 2017 | 2885 | 0.010 |
Why?
|
| Amino Acids | 1 | 2010 | 1718 | 0.010 |
Why?
|
| Haplotypes | 1 | 2010 | 2713 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2024 | 5880 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2010 | 3968 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 14605 | 0.010 |
Why?
|
| Cognition | 1 | 2019 | 6990 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2010 | 5439 | 0.010 |
Why?
|
| Alleles | 1 | 2010 | 6863 | 0.010 |
Why?
|
| Hypertension | 1 | 2019 | 8540 | 0.010 |
Why?
|
| Age Factors | 1 | 2015 | 18395 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2010 | 3065 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2010 | 4580 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 416 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2015 | 26198 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1996 | 389 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1996 | 1302 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 39967 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 15500 | 0.010 |
Why?
|
| Disease Progression | 1 | 2010 | 13506 | 0.010 |
Why?
|
| Infant | 1 | 2015 | 36192 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1996 | 1646 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 12690 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 15936 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 1996 | 2416 | 0.000 |
Why?
|
| Monocytes | 1 | 1996 | 2570 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1996 | 3688 | 0.000 |
Why?
|
| RNA | 1 | 1996 | 2726 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1996 | 2911 | 0.000 |
Why?
|
| Base Sequence | 1 | 1996 | 12441 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 17635 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1996 | 11076 | 0.000 |
Why?
|
| Macrophages | 1 | 1996 | 5769 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1996 | 18965 | 0.000 |
Why?
|
| Mice | 1 | 1996 | 81525 | 0.000 |
Why?
|
| Animals | 1 | 1996 | 168459 | 0.000 |
Why?
|